Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evommune (EVMN) Non-cash Items (2024 - 2025)

Evommune (EVMN) has disclosed Non-cash Items for 2 consecutive years, with $54.5 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items rose 9216.75% to $54.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $54.5 million through Dec 2025, up 9216.75% year-over-year, with the annual reading at $54.5 million for FY2025, 9216.75% up from the prior year.
  • Non-cash Items for Q4 2025 was $54.5 million at Evommune, up from $1.8 million in the prior quarter.
  • The five-year high for Non-cash Items was $54.5 million in Q4 2025, with the low at $585000.0 in Q4 2024.